Werth Lab
@werthlab
The Autoimmune Skin Disease Unit @Penn
Lab of Dr. Victoria Werth
#dermatomyositis #lupus #blistering
Managed by lab members
ID: 1377669512812634114
01-04-2021 17:10:04
369 Tweet
545 Followers
140 Following
We are at #SID2025 Society for Investigative Dermatology! We will be presenting several abstracts, tomorrow (5/8/25), looking forward to seeing you there!
Long-Term Safety and Efficacy of #Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with #Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study - JID Innovations Journal of Investigative Dermatology jidinnovations.org/article/S2667-…
Pathophysiology of Bullous #Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review) Advances in Therapy link.springer.com/article/10.100…
Effect of iberdomide on cutaneous manifestations in systemic #lupus erythematosus: A randomized phase 2 clinical trial. In JAAD Journals jaad.org/article/S0190-…
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project in ACR_Journals acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial in ACR_Journals acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…
Subtype and Racial Erythema Variation for Cutaneous #Lupus Trials by Lillian Xie and others from our group in JAMA Dermatology #DermTwitter jamanetwork.com/journals/jamad…
#Smoking status is a negative predictor of six-month cutaneous #lupus activity trends: A prospective cohort study in JAAD Journals by Tyler Cepica and investigators from the Chong Lab UTSW Dermatology and from our group! jaad.org/article/S0190-…
Risk of interstitial lung disease in adult patients with #dermatomyositis treated with methotrexate: A retrospective analysis of a prospective cohort in JAAD Journals jaad.org/article/S0190-…
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with #dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial in The Lancet thelancet.com/journals/lance…
Development and Evaluation of the #Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical Trials in Journal of Investigative Dermatology JID Innovations jidinnovations.org/article/S2667-…
📢 “There has not been a single approved drug for cutaneous #lupus in 75 years,” said Dr. Victoria P. Werth Werth Lab. Read the Healio Exclusive story Healio Rheumatology Healio Dermatology 👇 healio.com/news/rheumatol…
Serum IFNα as a Biomarker for Cutaneous #Lupus: Insights into Disease Activity, Severity, Therapeutic Monitoring and Clinical Trial Application in Journal of Investigative Dermatology by Touraj Khosravi! jidonline.org/article/S0022-…
Inter-Rater and Intra-Rater Reliability of the Cutaneous #Lupus Activity-Investigator Global Assessment-Revised Instrument in Journal of Investigative Dermatology UTSW Dermatology jidonline.org/article/S0022-…
Part B of the LILAC study of litifilimab for cutaneous #lupus erythematosus: a plain language summary #CLE Taylor & Francis Research Insights tandfonline.com/doi/abs/10.108…
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project Annals of the Rheumatic Diseases ard.eular.org/article/S0003-…
